4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-24-011572
Options or other derivatives
- Director acquired 19,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| THOMAS FRANK E Director | 2024-05-29 | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…